GW Pharmaceuticals (GW Pharmaceuticals) Dividend Payout Ratio : 0.00 (As of Mar. 2021)

View and export this data going back to . Start your Free Trial

What is GW Pharmaceuticals Dividend Payout Ratio?

GW Pharmaceuticals's dividend payout ratio for the months ended in Mar. 2021 was 0.00.

The historical rank and industry rank for GW Pharmaceuticals's Dividend Payout Ratio or its related term are showing as below:

GWPRF's Dividend Payout Ratio is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.33
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-05-05), the Dividend Yield % of GW Pharmaceuticals is 0.00%.

GW Pharmaceuticals's Dividends per Share for the months ended in Mar. 2021 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

GW Pharmaceuticals Dividend Payout Ratio Historical Data

The historical data trend for GW Pharmaceuticals's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GW Pharmaceuticals Dividend Payout Ratio Chart

GW Pharmaceuticals Annual Data

Trend

Sep11

Sep12

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Dec19

Dec20

Dividend Payout Ratio

Get a 7-Day Free Trial

GW Pharmaceuticals Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of GW Pharmaceuticals's Dividend Payout Ratio

For the Drug Manufacturers - General subindustry, GW Pharmaceuticals's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GW Pharmaceuticals's Dividend Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GW Pharmaceuticals's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where GW Pharmaceuticals's Dividend Payout Ratio falls into.

GW Pharmaceuticals Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

GW Pharmaceuticals's Dividend Payout Ratio for the fiscal year that ended in Dec. 2020 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2020 )	/	EPS without NRI (A: Dec. 2020 )
	=	0	/	-0.15
	=	N/A

GW Pharmaceuticals's Dividend Payout Ratio for the quarter that ended in Mar. 2021 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2021 )	/	EPS without NRI (Q: Mar. 2021 )
	=	0	/	-0.05
	=	N/A

GW Pharmaceuticals (OTCPK:GWPRF) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

GW Pharmaceuticals Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of GW Pharmaceuticals's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

GW Pharmaceuticals (GW Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GW Pharmaceuticals PLC (OTCPK:GWPRF) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sovereign House, Chivers Way, Vision Park, Histon, Cambridge, GBR, CB24 9BZ

Website

http://www.gwpharm.com

GW Pharmaceuticals PLC is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The company's lead product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol used for the treatment of a number of rare childhood-onset epilepsy disorders. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. Geographically its presence can be seen across the region of UK, Europe, US, Canada, and others.